CARGO Therapeutics, Inc. IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| CARGO Therapeutics, Inc. | CRGX - NASDAQ |
$15.00-$17.00 | $15.00 | $15.45 | 18.75 million | 11/10/2023 |
| J.P. Morgan, Jefferies, TD Cowen, Truist Securities | ||||||
Co-Manager(s): | ||||||
| Health Care | ||||||
Filing(s): Filed 2023-10-20 Terms Added 2023-11-06 | ||||||
CARGO Therapeutics, Inc. Quote & Chart - Click for current quote - CRGX
IPO Boutique aggregates information on public companies and private companies, such as "CRGX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About CARGO Therapeutics, Inc. (adapted from CARGO Therapeutics, Inc. prospectus):
They are a clinical-stage biotechnology company uniquely positioned to advance next generation, potentially curative cell therapies for cancer patients.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are a clinical-stage biotechnology company uniquely positioned to advance next generation, potentially curative cell therapies for cancer patients.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "CRGX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.